inflammatory bowel disease (ibd) Archives

Infliximab Weakens COVID Antibody Response for Patients With IBD

March 28, 2021 2019 Novel Coronavirus, 2019-nCoV, anti-tnf, anti-tumor necrosis factor, Coronavirus, Epidemiology, HCoV-229E, HCoV-OC43, Human coronavirus 229E, Human coronavirus HKU1, Human coronavirus OC43, IBD, inflammatory bowel disease, inflammatory bowel disease (ibd), pandemic, United Kingdom Site Content, wuhan coronavirus

Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated